These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 17926182

  • 1. Imatinib mesylate induced immune thrombocytopenia.
    Rajappa S, Varadpande L, Paul TR, Digumarti R.
    Leuk Lymphoma; 2007 Nov; 48(11):2261-3. PubMed ID: 17926182
    [No Abstract] [Full Text] [Related]

  • 2. Imatinib mesylate: a new pill for chronic myelogenous leukemia.
    Parmar KK, King RS.
    Cancer Pract; 2001 Nov; 9(5):263-5. PubMed ID: 11879324
    [No Abstract] [Full Text] [Related]

  • 3. Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate.
    Arora B, Kumar L, Sharma A, Wadhwa J, Kochupillai V.
    Ann Oncol; 2004 Feb; 15(2):358-9. PubMed ID: 14760137
    [No Abstract] [Full Text] [Related]

  • 4. Imatinib mesylate.
    Am J Health Syst Pharm; 2001 Dec 01; 58(23):2241-2. PubMed ID: 11765724
    [No Abstract] [Full Text] [Related]

  • 5. Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.
    Rousselot P, Larghero J, Raffoux E, Calvo F, Tulliez M, Giraudier S, Rybojad M.
    Br J Haematol; 2003 Mar 01; 120(6):1091-2. PubMed ID: 12648085
    [No Abstract] [Full Text] [Related]

  • 6. Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.
    Yamazaki R, Okamoto S, Chen CK, Tada S, Saito H, Shibata R, Sakamoto M, Mori T, Ikeda Y.
    Leuk Lymphoma; 2006 Jul 01; 47(7):1427-30. PubMed ID: 16923586
    [No Abstract] [Full Text] [Related]

  • 7. Unusual fluid retention with imatinib therapy for chronic myeloid leukemia.
    Ostro D, Lipton J.
    Leuk Lymphoma; 2007 Jan 01; 48(1):195-6. PubMed ID: 17325868
    [No Abstract] [Full Text] [Related]

  • 8. Precipitation of porphyria cutanea tarda by imatinib mesylate?
    Ho AY, Deacon A, Osborne G, Mufti GJ.
    Br J Haematol; 2003 Apr 01; 121(2):375. PubMed ID: 12694262
    [No Abstract] [Full Text] [Related]

  • 9. Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia.
    Prabhash K, Biswas G, Prasad N, Karant N, Sastry PS, Parikh PM.
    Indian J Dermatol Venereol Leprol; 2006 Apr 01; 72(1):63-4. PubMed ID: 16481719
    [No Abstract] [Full Text] [Related]

  • 10. [Imatinib mesylate-induced acute cytolytic hepatitis].
    Rocca P, El Jastimi S, Troncy J, Scoazec JY, Boucher A, Vial T, Trépo C, Zoulim F.
    Gastroenterol Clin Biol; 2004 Oct 01; 28(10 Pt 1):918-9. PubMed ID: 15523233
    [No Abstract] [Full Text] [Related]

  • 11. Gleevec: tailoring to fit.
    May TS.
    Drug Discov Today; 2003 Mar 01; 8(5):188-9. PubMed ID: 12634004
    [No Abstract] [Full Text] [Related]

  • 12. Leukemia. Q&A highlights.
    Frame D, Sessions J, Fausel C.
    Am J Health Syst Pharm; 2007 Dec 15; 64(24 Suppl 15):S22. PubMed ID: 18056929
    [No Abstract] [Full Text] [Related]

  • 13. Bilateral masculine mastoplasia associated with imatinib mesylate: a case report and literature review.
    Zhao D, Wang G, Li C, Meng L.
    J Huazhong Univ Sci Technolog Med Sci; 2011 Feb 15; 31(1):145-146. PubMed ID: 21336741
    [No Abstract] [Full Text] [Related]

  • 14. A patient of chronic myelogenous leukemia developing painful rash on feet.
    Kumar P, Das NK, Sil A, Chakrabarti P.
    J Postgrad Med; 2012 Feb 15; 58(4):331-4. PubMed ID: 23298941
    [No Abstract] [Full Text] [Related]

  • 15. Imatinib for chronic myeloid leukaemia: a NICE mess.
    Lim D, Muir J.
    Lancet; 2001 Dec 01; 358(9296):1903. PubMed ID: 11741656
    [No Abstract] [Full Text] [Related]

  • 16. Imatinib mesylate in the treatment of chronic myeloid leukaemia.
    Druker BJ.
    Expert Opin Pharmacother; 2003 Jun 01; 4(6):963-71. PubMed ID: 12783592
    [Abstract] [Full Text] [Related]

  • 17. Bilateral cystoid macular edema in a patient with chronic myeloid leukaemia under treatment with imanitib mesylate: report of an unusual side effect.
    Georgalas I, Pavesio C, Ezra E.
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct 01; 245(10):1585-6. PubMed ID: 17562067
    [No Abstract] [Full Text] [Related]

  • 18. Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose.
    Pavithran K, Thomas M.
    Indian J Dermatol Venereol Leprol; 2005 Oct 01; 71(4):288-9. PubMed ID: 16394445
    [No Abstract] [Full Text] [Related]

  • 19. [Molecular mechanism of imatinib-induced thrombocytopenia in treatment of patients with CML].
    Shu LL, Jiang QL, Meng FY, Yang M.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct 01; 19(5):1314-8. PubMed ID: 22040995
    [Abstract] [Full Text] [Related]

  • 20. Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia.
    Govind Babu K, Attili VS, Bapsy PP, Anupama G.
    Int Ophthalmol; 2007 Feb 01; 27(1):43-4. PubMed ID: 17410337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.